Abstract
The investigators seek to assess esophageal inflammation or lack of it in response to
treatment with a novel non-invasive method that would measure eosinophil-associated
inflammatory mediators in the blood and urine to determine the presence of active
Eosinophilic Esophagitis. For these purposes, the investigators will correlate esophageal
inflammatory mediators measured in blood and urine with histological findings identified on
esophageal mucosal biopsies. Additionally, biopsies associated mediators will be assessed
relative to clinical phenotype and outcome.

